Companies category powered by

IMER Cyprus: CAR-T cancer treatment may be administered out-patient

IMER medical services has announced that the Israeli CAR-T cancer treatment could be administered out-patient – which would be a first in world.

The therapy was developed at Hadassah University Hospital to treat Multiple Myeloma, AL Amyloidosis and other BCMA-positive malignancies.

Prof Polina Stepensky, Dr Shlomit Kfir-Erenfeld and Dr Nathalie Asherie of Hadassah’s Bone Marrow Transplantation Department, in collaboration with Prof Cyrille J. Cohen of Bar-Ilan University, developed the CAR-T treatment for myeloma.

Chimeric antigen receptor T-cell therapy is a treatment in which a patient’s T-cells are altered in a lab to attack cancer cells. Myeloma, AL amyloidosis and BCMA-positive malignancies are all types of blood cancers. The first two are generally found in the bone marrow.

iMER (International Medical Evaluation and Referrals) is a Worldwide Health Services Provider and the exclusive representative of Hadassah University Hospital in Greece and Cyprus since March 2007, with offices in Cyprus (Nicosia and Limassol) and Israel (in Hadassah hospital).

Read More

Services turnover value up in three sectors in Q3 2023
Cyprus aims to enhance economic cooperation with the US, President says (pics)
US entrepreneurs learn about Cyprus’ untapped business potential (pics)
Get ready for 'The Most Paradoxical Magical Festive Season' at Paradox Museum Limassol
CUT and Thammasat University sign cooperation agreement
Fiscal Council calls upon government to maintain debt-deficit trend, starting with 2025 budget
Cyprus participates in largest food and beverage exhibition in Austria
3 years Capacitor Partners: Expanding into new markets and service lines
Stella Kammitsi: Trusts are not limited to the rich and famous
UNIC mobile clinic and ‘Cy checkpoint’ partner for free HIV/syphilis screening in Nicosia